BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37338551)

  • 1. Head-to-head intra-individual comparison of total-body 2-[
    Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
    Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
    Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
    J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of total-body
    Hu Y; Liu G; Yu H; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the long axial field-of-view PET/CT with low-dose [
    Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated Reduced-Count Whole-Body FDG PET: Evaluation in Children and Young Adults Imaged on a Digital PET Scanner.
    Alves VPV; Brady S; Ata NA; Li Y; MacLean J; Zhang B; Sharp SE; Trout AT
    AJR Am J Roentgenol; 2022 Dec; 219(6):952-961. PubMed ID: 35731102
    [No Abstract]   [Full Text] [Related]  

  • 10. Image quality and lesion detectability in low-dose pediatric
    Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image Quality and Activity Optimization in Oncologic
    van Sluis J; Boellaard R; Dierckx RAJO; Stormezand GN; Glaudemans AWJM; Noordzij W
    J Nucl Med; 2020 May; 61(5):764-771. PubMed ID: 31628214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different hydration protocols for the quantification of healthy tissue uptake of half-dose
    Cao Y; Cai D; Sui X; Wang X; Song J; Tan H; Hu P; Zhang Y; Yu H; Shi H
    Quant Imaging Med Surg; 2023 Sep; 13(9):5701-5712. PubMed ID: 37711806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
    Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
    Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploration of the feasibility and clinical value of half-dose 5-h total-body
    Adili D; Cai D; Wu B; Yu H; Gu Y; Zhang Y; Shi H
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2375-2385. PubMed ID: 36864361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of imaging protocols for 18F-FDG PET/CT in overweight patients: optimizing scan duration versus administered dose.
    Masuda Y; Kondo C; Matsuo Y; Uetani M; Kusakabe K
    J Nucl Med; 2009 Jun; 50(6):844-8. PubMed ID: 19443586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
    Alberts I; Sachpekidis C; Prenosil G; Viscione M; Bohn KP; Mingels C; Shi K; Ashar-Oromieh A; Rominger A
    Ann Nucl Med; 2021 Apr; 35(4):485-492. PubMed ID: 33550515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Zheng S; Chen Z; Huang C; Chen Y; Miao W
    Ann Nucl Med; 2019 Feb; 33(2):135-143. PubMed ID: 30392070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining optimal tracer activities in pediatric oncologic whole-body
    Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.